(Q52586596)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

5 December 2020

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

main subject

theranostic nanomedicine

1 reference

5 December 2020

Katharina A Domnanich

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Christoph A Umbricht

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Nicholas P van der Meulen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Cristina Müller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

English

0 references

publication date

15 June 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Radiology

23 March 2020

1 November 2018

1 reference

5 December 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

5 December 2020

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

1091

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

20180074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial

23 March 2020

copyright license

1 reference

5 December 2020

Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy

1 reference

12 December 2020

Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy

1 reference

12 December 2020

Production of terbium-152 by heavy ion reactions and proton induced spallation

1 reference

12 December 2020

Dosimetric comparison of radionuclides for therapy of somatostatin receptor-expressing tumors

1 reference

12 December 2020

Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab

1 reference

12 December 2020

RADIOACTIVE IODINE AS AN INDICATOR IN THYROID PHYSIOLOGY. V. THE USE OF RADIOACTIVE IODINE IN THE DIFFERENTIAL DIAGNOSIS OF TWO TYPES OF GRAVES' DISEASE.

1 reference

12 December 2020

Saul Hertz, MD (1905-1950): a pioneer in the use of radioactive iodine.

1 reference

12 December 2020

Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.

1 reference

12 December 2020

Post-elution processing of (44)Ti/(44)Sc generator-derived (44)Sc for clinical application

1 reference

12 December 2020

Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals

1 reference

12 December 2020

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS

1 reference

12 December 2020

The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy

1 reference

12 December 2020

Comparison of receptor affinity of natSc-DOTA-TATE versus natGa-DOTA-TATE.

1 reference

12 December 2020

Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy

1 reference

12 December 2020

Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc

1 reference

12 December 2020

Imaging of protein synthesis: in vitro and in vivo evaluation of (44)Sc-DOTA-puromycin.

1 reference

12 December 2020

Scandium-44: benefits of a long-lived PET radionuclide available from the (44)Ti/(44)Sc generator system

1 reference

12 December 2020

Cyclotron produced ⁴⁴gSc from natural calcium.

1 reference

12 December 2020

44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?

1 reference

12 December 2020

A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.

1 reference

12 December 2020

Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate

1 reference

12 December 2020

Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate

1 reference

12 December 2020

Future prospects for SPECT imaging using the radiolanthanide terbium-155 - production and preclinical evaluation in tumor-bearing mice

1 reference

12 December 2020

Folate receptor targeted alpha-therapy using terbium-149.

1 reference

12 December 2020

Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.

1 reference

12 December 2020

Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice.

1 reference

12 December 2020

(44)Sc: an attractive isotope for peptide-based PET imaging.

1 reference

12 December 2020

Matching the decay half-life with the biological half-life: ImmunoPET imaging with (44)Sc-labeled cetuximab Fab fragment

1 reference

12 December 2020

Separation of cyclotron-produced (44)Sc from a natural calcium target using a dipentyl pentylphosphonate functionalized extraction resin.

1 reference

12 December 2020

(47)Ca production for (47)Ca/(47)Sc generator system using electron linacs.

1 reference

12 December 2020

Sc-47 production from titanium targets using electron linacs

1 reference

12 December 2020

Cyclotron production of (44)Sc: From bench to bedside.

1 reference

12 December 2020

Stability of (47)Sc-complexes with acyclic polyamino-polycarboxylate ligands.

1 reference

12 December 2020

Cyclotron production of (43)Sc for PET imaging

1 reference

12 December 2020

Scandium(III) complexes of monophosphorus acid DOTA analogues: a thermodynamic and radiolabelling study with (44)Sc from cyclotron and from a (44)Ti/(44)Sc generator.

1 reference

12 December 2020

68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.

1 reference

12 December 2020

Imaging quality of (44)Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET.

1 reference

12 December 2020

Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folate.

1 reference

12 December 2020

Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging

1 reference

12 December 2020

Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer

1 reference

12 December 2020

225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer.

1 reference

12 December 2020

Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease

1 reference

12 December 2020

Production of scandium-43 and -47 from a powdery calcium oxide target via the (nat/44)Ca(α,x)-channel

1 reference

12 December 2020

Production of medical Sc radioisotopes with an alpha particle beam.

1 reference

12 December 2020

PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013.

1 reference

12 December 2020

Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors.

1 reference

12 December 2020

Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer

1 reference

12 December 2020

AAZTA: An Ideal Chelating Agent for the Development of 44 Sc PET Imaging Agents.

1 reference

12 December 2020

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617.

1 reference

12 December 2020

213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer.

1 reference

12 December 2020

First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced 44Sc-DOTATOC: A Proof-of-Concept Study.

1 reference

12 December 2020

177Lu-PSMA Radioligand Therapy for Prostate Cancer

1 reference

12 December 2020

47Sc production development by cyclotron irradiation of 48Ca.

1 reference

12 December 2020

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC.

1 reference

12 December 2020

Theranostics in nuclear medicine practice

1 reference

12 December 2020

Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer

1 reference

12 December 2020

Electron linear accelerator production and purification of scandium-47 from titanium dioxide targets

1 reference

12 December 2020

Actual impact of 68Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence.

1 reference

12 December 2020

Sc as useful β-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes

1 reference

12 December 2020

Production and separation of Sc for radiopharmaceutical purposes

1 reference

12 December 2020

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics

1 reference

12 December 2020

Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations

1 reference

12 December 2020

Identifiers

DOI

10.1259/BJR.20180074

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29658792%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

PubMed publication ID

29658792

1 reference